Company news

Mayne Pharma Group Ltd. news in 2026

Mayne Pharma Group Ltd.'s news releases, calls and decks from 2026, newest first.

View company

Notification regarding unquoted securities - MYX

October 29, 2026

Notification regarding unquoted securities - MYX

October 29, 2026

Notification regarding unquoted securities - MYX

October 29, 2026

Investor presentation

October 25, 2026

Mayne Pharma reports unaudited Q1 FY27 results

October 25, 2026

2026 Notice of Annual General Meeting and shareholder pack

October 18, 2026

MYX settles US patent litigation re Imvexxy with Teva USA

October 15, 2026

Supreme Court Decision in Cosette Proceedings

October 13, 2026

Trading Halt

October 13, 2026

Fulfilment of Imvexxy post-marketing study requirements

October 8, 2026

Notification of cessation of securities - MYX

October 7, 2026

MYX settles US patent litigation re Imvexxy with Sun Pharma

September 29, 2026

Mayne Pharma announces legal settlement

September 27, 2026

Date for Annual General Meeting

September 27, 2026

MYX signs licence agreement for Blissel in Australia

September 14, 2026

Notification of cessation of securities - MYX

September 8, 2026

Notification regarding unquoted securities - MYX

September 8, 2026

Application for quotation of securities - MYX

August 28, 2026

2026 Full Year Results Media Release

August 26, 2026

2026 Appendix 4E and Annual Report

August 26, 2026

2026 Full Year Results Investor Presentation

August 26, 2026

2026 Corporate Governance Statement and Appendix 4G

August 26, 2026

Notification of date for release of FY26 results

August 20, 2026

Upcoming presentation of Imvexxy clinical data

August 19, 2026

Mayne Pharma launches Investor Hub

August 17, 2026

Initial Director's Interest Notice

August 14, 2026

Mayne Pharma Bioshares Summit Presentation

August 5, 2026

Notification of cessation of securities - MYX

August 5, 2026

Notification regarding unquoted securities - MYX

August 5, 2026

Non-Executive Director appointment

August 4, 2026

Mayne Pharma to present at the 20th Bioshares Summit

August 3, 2026

Mayne Pharma reports unaudited Q4 and FY26 results

July 30, 2026

Mayne Pharma receives $14.4m for legal costs from Cosette

June 4, 2026

Court awards MYX $13.27m for legal costs from Cosette

May 21, 2026

Mayne Pharma reports unaudited 3Q FY26 results

April 28, 2026

S&P DJI Announces March 2026 Quarterly Rebalance

March 6, 2026

Mayne Pharma management changes

February 23, 2026

2026 Half Year Investor Presentation

February 22, 2026

2026 Half Year Media Release

February 22, 2026

Half Yearly Report and Accounts

February 22, 2026

Mayne Pharma Management Changes

February 22, 2026

MYX to claim against Cosette, Avista & Mr David Burgstahler

February 17, 2026

2025 AGM presentation and business update

January 28, 2026

Calls in 2026

Decks in 2026